Summary Keywords ER/, GPER1/GPR30, 17-estradiol, bisphenol A, Alzheimers disease, Parkinsons disease, hormone replacement therapy, neural stem/progenitor cells Citation Bustamante-Barrientos FA, Mndez-Ruette M, Ortloff A, Luz-Crawford P, Rivera FJ, Figueroa CD, Molina L and Btiz LF (2021) The Impact of Estrogen and Estrogen-Like Molecules in Neurogenesis and Neurodegeneration: Beneficial or Harmful
While GLP-1 therapies are known for achieving greater weight loss compared to controls, they often come with side effects like nausea, vomiting, and dizziness, which lead many patients to stop treatment prematurely
Waist circumference
The efficacy and safety of once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitusa systemic review and meta-analysis